For Lung Cancer Awareness Month, five numbers from federal and American Cancer Society data show how survival for people with lung cancer has changed, how it differs by stage and type, and how many people are living with the disease.
|Articles|May 3, 2023
Self Breast Examination
Advertisement
While self breast exams are not a formal screening modality, there is great value in being familiar with the look and feel of your own breasts so you understand what is normal to you and are able to detect and promptly report changes.
While we are proponents of breast self exams and knowing your body, it is important to know that BSEs should never take the place of breast cancer screenings.
Advertisement
Related to this article
A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.
An Ohio State hematologist discusses a new trial comparing tovorafenib plus rituximab with standard cladribine-based treatment, and what quality of life means for patients.
Adding Anktiva to BCG led to better responses than BCG alone in people with high-risk bladder cancer who had not yet received BCG, the company said.
An Ohio State hematologist explains how she weighs chemotherapy against targeted drugs, what side effects patients should expect and why learning about this specific leukemia matters.
Leanne Citrone shares how a BRCA mutation, an elective mastectomy and a stage 2C ovarian cancer diagnosis shaped her outlook, anxiety and advice to others.
A colon cancer survivor who cared for her mother with lung cancer shares how she learned to speak up, plus tips for advocating for yourself or a loved one.
Medicare's Part D out-of-pocket cap rises to $2,400 in 2027. Here is what that means for people taking costly oral cancer drugs, how the monthly payment plan works with it and what to check before open enrollment ends Dec. 7.
Advertisement
Advertisement
Trending on CURE
1
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
2
Anktiva Plus BCG Meets Main Goal in BCG-Naive Bladder Cancer Trial
3
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
4
Tattoos and Lymphoma Risk: A Breast Cancer Survivor's Questions
5